Position in PEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$64,140,823
-$50,472,784 QoQ
Shares Held
203,138
-41.8% QoQ
Ownership
0.516%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#37
of 446 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Derivatives in PEN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$9,567,225
PutShares
30,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $434,636,902 across 12 Medical Devices names. PEN ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,600,000 | $145,184,000 | |
| 2 | ITGR |
Integer Holdings Corp
|
1,000,000 | $93,450,000 | |
| 3 | PEN |
Penumbra Inc
This page
|
203,138 | $64,140,823 | |
| 4 | NEOG |
Neogen Corp
|
6,500,000 | $58,435,000 | |
| 5 | BSX |
Boston Scientific Corp
|
742,896 | $31,706,800 | |
| 6 | PODD |
Insulet Corp
|
155,000 | $23,598,750 | |
| 7 | MDT |
Medtronic plc
|
120,000 | $9,387,600 | |
| 8 | EW |
Edwards Lifesciences Corp
|
89,100 | $8,059,986 |
All Filings in PEN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,567,225 | 30,300 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $64,140,823 | 203,138 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $114,613,607 | 349,038 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||